Skip to main navigation Skip to search Skip to main content

Spectrum of fibrotic lung diseases

  • Faiz Karim*
  • , Jan van Laar
  • , Martin van Hagen
  • *Corresponding author for this work
  • Groene Hart Ziekenhuis

Research output: Contribution to journalComment/Letter to the editorProfessionalpeer-review

2 Citations (Scopus)

Abstract

To the Editor:
The review article by Wijsenbeek and Cottin (Sept. 3 issue)1 provides an excellent overview of the spectrum of fibrotic lung diseases. To this discussion, we would add IgG4-related disease, a distinct primary disease causing interstitial lung disease. IgG4-related disease may affect all parts of the human body (including the lungs), may mimic such conditions as cancer and sarcoidosis, and is an increasingly recognized inflammatory disease characterized by progressive fibrosis. Reported manifestations of IgG4-related lung disease include tumorlike lesions, enlargement of hilar or mediastinal lymph nodes, bronchiectasis, bronchovascular nodules, organizing pneumonia, isolated non-specific interstitial pneumonia,2,3 and interstitial pneumonia with autoimmune features.2-4 The timely diagnosis and treatment of IgG4-related lung disease is important to prevent further progression of fibrosis.
Original languageEnglish
Pages (from-to)2485-2486
JournalNew England Journal of Medicine
Volume383
Issue number25
DOIs
Publication statusPublished - 16 Dec 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Spectrum of fibrotic lung diseases'. Together they form a unique fingerprint.

Cite this